NCT06435299View on ClinicalTrials.gov

Efficacy and Tolerance of Cannabidiol in Patients with Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Pruritus
Interventions
DRUG

Cannabis oil

Patients in this arm will have to take Cannabis oil (50mg/mL) twice a day with the daily dose estimated during auto titration phase (from W0 to W2)

DRUG

Placebo

Patients in this arm will have to take Placebo oil twice a day with the daily dose estimated during auto titration phase (from W0 to W2)

Trial Locations (7)

17300

Groupe Hospitalier La Rochelle, La Rochelle

35033

CHU de Rennes, Rennes

37044

CHRU de Tours, Tours

44093

CHU de Nantes, Nantes

49000

CHU Angers, Angers

85925

CHD Vendée, La Roche-sur-Yon

86000

CHU de Poitiers, Poitiers

All Listed Sponsors
lead

University Hospital, Brest

OTHER